KeywordsParkinson's disease, rapid eye movement (REM) sleep behavior disorder, neurodegeneration, Parkinsonism, biomarkers, autonomic dysfunction, olfactory dysfunction Disclosure: Nuri Jacoby, MD, and Jacqueline B Stone, MD, have no conflicts of interest to declare. Claire Henchcliffe, MD, DPhil, has served on advisory boards for GE, Teva Pharmaceuticals, and UCB, and serves on the speakers' bureaus of Novartis and Teva Pharmaceuticals.